Open AccessP42 Determining the efficacy of advanced glycated end products inhibitor, vonder® on disease outcome in osteoarthritis patients (vonder®: benfotiamine 50 mg + pyridoxamine 50 mg + methylcobalamin 500 mg)
Author(s) -
Ashit Syngle,
Kanchan Vohra,
Palvi Gupta
Publication year - 2010
Publication title -
indian journal of rheumatology/indian journal of rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.155
H-Index - 11
eISSN - 0973-3701
pISSN - 0973-3698
DOI - 10.1016/s0973-3698(10)60656-5
Subject(s) - methylcobalamin , medicine , osteoarthritis , pyridoxamine , pharmacology , vitamin b12 , pathology , vitamin , alternative medicine , vitamin b6